March 24, 2015 +44 (0)20 7025 7911 [email protected]

The Development Pipeline

VIP Pipeline

VIP has a robust development pipeline with recombinant Coversin due to enter Phase II/III in 2015 in five clinical areas: haematology, ophthalmology, neurology, nephrology and respiratory.

Contact Us

We're not around right now. But you can send us an email and we'll get back to you, asap.